Ligne de temps
Yu Wei
Chef(fe) de Groupe
19 déc. 2023
publication
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.
Lire plus21 déc. 2022
publication
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Lire plus28 sept. 2016
publication
Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma
Lire plus05 nov. 2015
publication
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress
Lire plus06 juil. 2015
project
Molecular mechanisms regulating hepatitis B virus replication and liver carcinogenesis
Lire plus01 août 2013
publication
LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.
Lire plus28 févr. 2013
publication
The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b
Lire plus15 janv. 2013
publication
The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia
Lire plus11 juil. 2012
publication
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis
Lire plus18 mai 2010
28 avr. 2010
publication
Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice
Lire plus01 déc. 2008
publication
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer
Lire plus19 nov. 2008
publication
The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways
Lire plus31 mars 2008
publication
The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation
Lire plus01 févr. 2007
publication
Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer
Lire plus01 mai 2006
13 févr. 2003
01 sept. 2002
publication
Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features
Lire plus01 juin 2002
27 janv. 2000
01 sept. 1999
publication